Use access key #2 to skip to page content.

FoxForce5contest (25.40)

July 2013

Recs

3

TheFoxForceJournal

July 27, 2013 – Comments (4) | RELATED TICKERS: MO

Holy cow! yet another edition of the award winning FoxForceJournal.  [more]

Recs

3

TheFoxForceJournal

July 27, 2013 – Comments (5) | RELATED TICKERS: TPZ

Greetings my fellow Foxies,  [more]

Recs

5

TheFoxForceJournal

July 27, 2013 – Comments (7) | RELATED TICKERS: SDRL

First my apologies to Shareplanner and inthemoneystocks for pushing your blogs off the main page, you'll have many more the day to pimp your websites.   [more]

Recs

5

TheFoxForceJournal

July 27, 2013 – Comments (1) | RELATED TICKERS: VNR

Welcome to yet another edition of TheFoxForceJournal  [more]

Recs

6

TheFoxForceJournal

July 27, 2013 – Comments (3) | RELATED TICKERS: SAN

Greetings my fellow foxies, our featured stock is Banco Santander Central Hispano SA (ADR). Wow that was a lot to type let's just go with (NYSE: SAN). Or we could even go with the more amusing ticker of (STD) if you wanna go all old school.   [more]

Recs

4

TheFoxForceJournal

July 23, 2013 – Comments (3) | RELATED TICKERS: FSC

Greetings my fellow Foxies.  [more]

Recs

7

TheFoxForceJournal

July 19, 2013 – Comments (2) | RELATED TICKERS: PNNT

Greetings my fellow Foxies, and welcome to a very rare- day off of work cause it's freakin' hot out there... edition of TheFoxForceJournal  [more]

Recs

8

TheFoxForceJournal

July 11, 2013 – Comments (11) | RELATED TICKERS: PDLI


Get Profile for: PDL BioPharma, Inc.
932 Southwood Boulevard
Incline Village, NV 89451
United States - Map
Website: http://www.pdl.com

Details Index Membership:N/ASector:HealthcareIndustry:BiotechnologyFull Time Employees:10
Business Summary 

PDL BioPharma, Inc. engages in intellectual property asset management and patent portfolio and related assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases, as well as other medical conditions. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.  [more]

Featured Broker Partners


Advertisement